Acute sarcopenia will be defined as the incidence of sarcopenia compared to baseline measurements at recruitment, using the European Working Group on Sarcopenia in older people 2 (EWGSOP2) criteria
Diagnostic TestThe study procedures include:
- Handgrip dynamometry to evaluate muscle strength using a standardized dynamometer.
- Bioelectrical impedance analysis (BIA) and ultrasound of the anterior thigh to measure muscle mass.
No comparator procedure is foreseen. The regimen includes baseline assessment within 24 hours of admission, repeated evaluations on days 3, 5, 7, 10, and every five days until discharge (on average maximum 20 days after hospital admission), with follow-up visits at 3 and 6 months post-discharge.